Track topics on Twitter Track topics that are important to you
Over-the-counter antioxidant lipoic acid holds promise for treating patients with secondary progressive multiple sclerosis, a pilot study suggests. Researchers are using the findings from the pilot trial to design the expanded multi-site clinical trial to begin later this year in Portland and other sites that have yet to be finalized.
Original Article: Multiple sclerosis: Patients may benefit from over-the-counter therapyNEXT ARTICLE
Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...